Title: Complications of Renal Biopsy A Single Centre Experience
Authors: Dr Ashaq Hussain Parrey, Dr Khurshid Ahmad Banday, Dr Imtiyaz Ahmad, Dr Mir Waseem
DOI: https://dx.doi.org/10.18535/jmscr/v4i10.51
Abstract
Introduction: Renal biopsy is a procedure in which a sample of renal tissue is obtained for diagnosis of renal diseases. Major complications of renal biopsy include gross hematuria or retroperitoneal hematoma requiring blood transfusion, invasive procedure or surgical intervention and rarely sepsis.
Aims and Objectives:-To study the complications of renal biopsy.
Materials and Methods: In this prospective study 345 patients underwent renal biopsy over 2.5 years from 2009 to 2012.
Results: In this prospective study 345 renal biopsies were performed in 210 males (60.9%) and 135 females (39.1%). The mean age of males were 36 ± 14.3 and in females mean age was 29.6 + 12.8 the most common age group biopsied was between 19-45yrs of age both among males (58.6%) and females (66.7) respectively. The number of patients below 18yrs of age were 63 (18.3%), 33 male and 30 female. Patients above the age of 45 were 69 (20%) 54 males and 15 females. Pain was the most common complication in our study out of 345 patients 141 (40.9%) complained of some sort of pain during initial 24hrs of hospital stay. Second most common complication was gross hematuria 69 patients (20%), hematoma in 9.3%, pylonephritis in 0.9%, AV fistula 0.9%. There was increased incidence of gross hematuria and hypotension in patients with prolonged prothrombin time with P value=0.035.
Conclusion: The complications do occur with renal biopsy, but with proper pre and post procedure management they can be reduced significantly if not eliminated at all. In our study prolonged prothrombin time was associated with increased risk of hypotension and hematuria.
Keywords:-Renal, biopsy, complications.
References
1. Iversen P, Brun C. Aspiration biopsy of the kidney. 1951. J Am Soc Nephrol. 1997;8:1778-1787, discussion 1778-1786.
2. Alwall N. Aspiration biopsy of the kidney, including i.a. a report of a case of amyloidosis diagnosed through aspiration biopsy of the kidney in 1944 and investigated at an autopsy in 1950. Acta Med Scand. 1952;143:430-435
3. Tisher CC. Clinical indication for kidney biopsy (chaps 3) in Renal Pathology (2nd ed) edited by Tisher CC, Brenner BM, Philadelphia, JB Lippincott Company 1989, pp75-84.
4. Pirani CL. Evaluation of kidney biopsy specimens. In Clinical indications for kidney biopsy. In Renal Pathology: with clinical and functional correlations. 2nd Ed. 'Fisher CG and Brenner 13M eds. JB Lippincott Company; Philadelphia, 1994, p 85-115
5. Madaio MP. Renal biopsy. Kidney Int; 38: 529-543, 1990.
6. Tisher CC, Croker 13P. Indications for and interpretation of the renal biopsy: Evaluation by light, electron and immune-fluorescence microscopy. In: Diseases of the kidney, 5th ed., edited by Schrier RW, Gottshalk CW, Boston, Little, Brown and Co, 1997, pp 485-510.
7. William L. Whittier and Stephen M. Korbet Section of Nephrology, Departm-ent of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois J Am Soc Nephrol 15: 142-147,2004
8. Lefaucheur C, Nochy D, Bariety. J Nephrol Tiler. 2009 Jul: 5(4):331-9
9. Korbet SM: Percutaneous renal biopsy. Semin Nephrol 22: 254–267,2002
10. Diaz-Buxo JA, Donadio JV Jr: Complications of percutaneous renal biopsy: An analysis of 1,000 consecutive biopsies. Clin Nephrol 4: 223–227, 1975
11. Christensen J, Lindequist S, Knudsen DU, Pedersen RS: Ultrasound-guided renal biopsy with biopsy gun technique-efficacy and complications. Acta Radiol 36: 276–279, 1995
12. Hergesell O, Felten H, Andrassy K, et al: Safety of ultrasoundguided percutaneous kidney biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 13:975–977, 1998.
13. Preda A, Van Dijk LC, Van Oostaijen JA, et al: Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun. Eur Radiol 13:527–530, 2003.
14. Whittier WL, Korbet SM: Timing of complications in percutaneous kidney biopsy. J Am Soc Nephrol 15:142–147, 2004.
15. Bolton WK: Nonhemorrhagic decrements in hematocrit values after percutaneous renal biopsy. JAMA 238: 1266–1268, 1977
16. Burstein DM, Korbet SM, Schwartz MM: The use of the automatic core biopsy system in percutaneous renal biopsies: A comparative study. Am J Kidney Dis 22: 545–552, 1993
17. Khajehdehi P, Junaid SM, Salinas-Madrigal L, Schmitz PG, Bastani B: Percutaneous renal biopsy in the 1990s: Safety, value, and implications for early hospital discharge. Am J Kidney Dis 34: 92–97, 1999
18. Ishikawa E, Nomura S, Hamaguchi T, Obe T, Inoue-Kiyohara Oosugi K, Katayama K, Ito M. Clin Exp Nephrol. 2009 Aug; 13(4):325-31
19. Carlo Manno, Giovanni F.M. Strippoli, Loredana Arnesano, Carmen Bonifati, Nicla Campobasso, Loreto Gesualdo, and Francesco P. Schena Kidney International, Vol. 66 (2004), pp. 1570-1577.
20. Prakash J, Singh M, Tripathi K, Rai US. Complications of percutaneous renal biopsy. Journal of the Indian Medical Association. 1994 Dec; 92(12): 395-6.